U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160998) titled 'An Active Health-Based Comprehensive Study on Diabetes Management' on Aug. 22.
Brief Summary: This randomized, open-label, multicenter trial evaluates the efficacy and safety of the AI-based lifestyle guidance system (X Life) compared to standard care in adults with type 2 diabetes. X Life integrates CGM, wearable devices, and AI-driven decision models to provide personalized lifestyle recommendations. The primary endpoint is the percentage of time in glucose target range (TIR).
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Diabetes
Intervention:
OTHER: Digital Lifestyle Therapeutic
Personalized real-time l...